GSK2578215A,
GSK2578215A,
1285515-21-0,
2-(benzyloxy)-5-(2-fluoropyridin-4-yl)-N-(pyridin-3-yl)benzamide,
UNII-Q641JSF42X,
Q641JSF42X,
CHEMBL2204495,
GSK257821A,
AK174163,
Benzamide, 5-(2-fluoro-4-pyridinyl)-2-(phenylmethoxy)-N-3-pyridinyl-,
C24H18FN3O2,
5-(2-fluoropyridin-4-yl)-2-phenylmethoxy-N-pyridin-3-ylbenzamide,
LRRK2-kinase inhibitor,
WCIGMFCFPXZRMQ-UHFFFAOYSA-N,
GSK-2578215A,
SCHEMBL10321469,
AOB6080,
BCP07701,
EX-A1118,
KS-00000T3G,
2446AH,
5-(2-Fluoro-4-pyridinyl)-2-(phenylmethoxy)-N-3-pyridinylbenzamide,
BDBM50401284,
GSK 2578215A,
GSK2578215-A,
MFCD22665702,
s7664,
ZINC68267183,
AKOS024458262,
CS-3516,
NCGC00370783-06,
BC600629,
HY-13237,
QC-11747,
FT-0700156,
J-005608,
5-(2-Fluoro-4-pyridinyl)-2-[(phenylmethyl)oxy]-N-3-pyridinylbenzamide,
B5659,
A12798,